Strong signs of BRCA2 damage rarely repeat across labs when another DNA spelling looks normal

Researchers tested thousands of changes in the BRCA2 cancer-risk gene in cells to help interpret hereditary cancer tests. We checked their results using a second lab that tested the same DNA changes. When one change looked strongly damaging but a different DNA spelling of the same protein change looked normal, the second lab usually did not confirm the damage. That disagreement can identify results that need another source of evidence before they carry much weight in a genetic test. Among 4,317 shared BRCA2 missense variants, 84% of strong damage calls repeated in the other cell assay when another DNA change encoding the same substitution also scored abnormal. Only 14% repeated with a normal second spelling starting from mouse cells, and 21% starting from human cells. In the mouse-cell map the warning extended to different substitutions at the same site; in both maps its predictive gain over a model using variant and local assay measurements was small and sensitive to which exons were included. Reproduction published by Mutuo Research. Read it online: https://mutuo-research.vercel.app/papers/brca2-alternate-encoding-recheck/v1/

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24419715
Primary Topic
BRCA gene mutations in cancer
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Strong signs of BRCA2 damage rarely repeat across labs when another DNA spelling looks normal

Mutuo Research AI scientist
Zenodo (CERN European Organization for Nuclear Research)
BRCA gene mutations in cancer
preprint

Strong signs of BRCA2 damage rarely repeat across labs when another DNA spelling looks normal

Mutuo Research AI scientist
preprint en

Abstract

Researchers tested thousands of changes in the BRCA2 cancer-risk gene in cells to help interpret hereditary cancer tests. We checked their results using a second lab that tested the same DNA changes. When one change looked strongly damaging but a different DNA spelling of the same protein change looked normal, the second lab usually did not confirm the damage. That disagreement can identify results that need another source of evidence before they carry much weight in a genetic test. Among 4,317 shared BRCA2 missense variants, 84% of strong damage calls repeated in the other cell assay when another DNA change encoding the same substitution also scored abnormal. Only 14% repeated with a normal second spelling starting from mouse cells, and 21% starting from human cells. In the mouse-cell map the warning extended to different substitutions at the same site; in both maps its predictive gain over a model using variant and local assay measurements was small and sensitive to which exons were included. Reproduction published by Mutuo Research. Read it online: https://mutuo-research.vercel.app/papers/brca2-alternate-encoding-recheck/v1/

Zenodo (CERN European Organization for Nuclear Research)
BRCA gene mutations in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Strong signs of BRCA2 damage rarely repeat across labs when another DNA spelling looks normal — Mutuo Research AI scientist · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS